会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • ERYSIPELOTHRIX RHUSIOPATHIAE-HAEMOPHILUS PARASUIS VACCINE AND METHODS OF USING THE SAME
    • ERYSIPELOTHRIX RHUSIOPATHIAE-HAEMOPHILUS PARASUIS疫苗及其使用方法
    • WO2005041890A2
    • 2005-05-12
    • PCT/US2004/036336
    • 2004-10-29
    • BOEHRINGER INGELHEIM VETMEDICA, INC.SWART, John, RandallVAUGHN, Eric, MartinFREKING, KAREN, E.ROOF, Michael, B.HAYES, Phillip, WaynePHILLIPS, Reid, C.
    • SWART, John, RandallVAUGHN, Eric, MartinFREKING, KAREN, E.ROOF, Michael, B.HAYES, Phillip, WaynePHILLIPS, Reid, C.
    • A61K
    • A61K39/102A61K39/0241A61K2039/54A61K2039/552A61K2039/55566
    • The present invention provides a composition and an improved single dose vaccine against E. rhusiopathiae and an improved single dose vaccine against E. rhusiopathiae and H. parasuis which provides one or more of the following: 1) confers effective immunity against E. rhusiopathiae and/or H. parasuis ; 2) decreases the risk of developing clinical signs of E. rhusiopathiae and/or H. parasuis infection; 3) induces an immune response against E. rhusiopathiae and/or H. parasuis ; and 4) has a DOI against E. rhusiopathiae and/or H. parasuis of at least four months. The composition or E. rhusiopathiae vaccine as well as the combined E. rhusiopathiae-H. parasuis composition or vaccine each includes a bacterial component of inactivated E. rhusiopathiae bacteria and a suitable adjuvant. The combined E. rhusiopathiae-H. parasuis composition or vaccine further includes an amount of H. parasuis antigen. The vaccines can be administered to animals in any conventional manner. The amount of the dose for intramuscular administration is preferably less than 5 ml. The amount of E. rhusiopathiae and/or H. parasuis antigen in each dose should be enough to induce an immune response in the animal receiving the vaccine or composition and will preferably confer effective immunity against and decrease the risk of developing clinical signs resulting from E. rhusiopathiae and/or H. parasuis infection for a suitable duration of immunity.
    • 本发明提供了针对E的组合物和改进的单剂量疫苗。 以及改善抗猪红斑丹毒丝菌和H的单剂量疫苗。 提供以下一种或多种方法的副猪嗜血杆菌:1)赋予针对E的有效免疫力。 (rhusiopathiae)和/或H。 副猪嗜血杆菌的; 2)降低发展为E的临床体征的风险。 猪红斑痤疮和/或副猪嗜血杆菌感染; 3)诱导针对E的免疫应答。 (rhusiopathiae)和/或H。 副猪嗜血杆菌的; 和4)具有针对E的DOI。 (rhusiopathiae)和/或H。 副猪至少四个月。 该组合物或E。 rhusiopathiae疫苗以及组合的E。 丝菌-H。 副猪嗜血杆菌组合物或疫苗各自包含灭活E的细菌组分。 猪红斑丹毒丝菌和一种合适的佐剂。 合并的E。 丝菌-H。 副猪嗜血杆菌组合物或疫苗还包含一定量的H。 副猪嗜血杆菌抗原。 疫苗可以以任何常规方式给予动物。 肌内给药的剂量优选小于5ml。 猪红斑痤疮和/或H的量。 每种剂量的副猪嗜血杆菌抗原应足以在接受疫苗或组合物的动物中诱导免疫应答,并且将优选赋予针对由E引起的临床体征的有效免疫力并降低产生临床体征的风险。 (rhusiopathiae)和/或H。 副猪嗜血杆菌感染一段时间的免疫力。